Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about INFLAMMASOME: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | INFLAMMASOME |
| Key Genes/Proteins | IL-18, CASP1, TNF, UBIQUITIN, NF-KB |
| Related Diseases | M1 Polarization, Multiple Sclerosis, Alzheimer's Disease, Parkinson's Disease, ALZHEIMER'S DISEASE |
| Linked Hypotheses | 7 hypotheses |
Knowledge base pages for this entity
graph TD
INFLAMMASOME["Inflammasome"]
NLRP3["NLRP3"]
PYCARD["PYCARD/ASC"]
MICROGLIA["Microglia"]
INFLAMMATION["Inflammation"]
TNF["TNF-alpha"]
IL1B["IL-1beta"]
NEURODEGENERATION["Neurodegeneration"]
PARKINSON["Parkinson's Disease"]
MULTIPLE_SCLEROSIS["Multiple Sclerosis"]
SNCA["alpha-synuclein (SNCA)"]
PARKIN["Parkin"]
AUTOPHAGY["Autophagy"]
UBIQUITIN["Ubiquitin System"]
NLRP3 -->|"forms"| INFLAMMASOME
PYCARD -->|"assembles"| INFLAMMASOME
INFLAMMASOME -->|"activates"| MICROGLIA
INFLAMMASOME -->|"triggers"| INFLAMMATION
INFLAMMASOME -->|"releases"| TNF
INFLAMMASOME -->|"releases"| IL1B
INFLAMMATION -->|"promotes"| NEURODEGENERATION
MICROGLIA -->|"amplifies"| INFLAMMATION
SNCA -->|"activates"| INFLAMMASOME
NEURODEGENERATION -->|"leads to"| PARKINSON
NEURODEGENERATION -->|"contributes to"| MULTIPLE_SCLEROSIS
INFLAMMASOME -->|"impairs"| AUTOPHAGY
PARKIN -->|"regulates"| AUTOPHAGY
AUTOPHAGY -->|"clears"| SNCA
INFLAMMASOME -->|"activates"| UBIQUITIN
style INFLAMMASOME fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
style AUTOPHAGY fill:#1b5e20,stroke:#333,stroke-width:2px
style PARKIN fill:#1b5e20,stroke:#333,stroke-width:2px
style NEURODEGENERATION fill:#ef5350,stroke:#333,stroke-width:2px
style INFLAMMATION fill:#ef5350,stroke:#333,stroke-width:2px
style PARKINSON fill:#7d4200,stroke:#333,stroke-width:2px
style MULTIPLE_SCLEROSIS fill:#7d4200,stroke:#333,stroke-width:2px
style NLRP3 fill:#4a1a6b,stroke:#333,stroke-width:2px
style SNCA fill:#4a1a6b,stroke:#333,stroke-width:2px
style TNF fill:#4a1a6b,stroke:#333,stroke-width:2px| Target | Relation | Type | Str |
|---|---|---|---|
| Metabolic Reprogramming | causes | process | 0.90 |
| M1 Polarization | causes | phenotype | 0.88 |
| MICROGLIA | interacts_with | cell_type | 0.86 |
| AUTOPHAGY | activates | process | 0.86 |
| Multiple Sclerosis | involved_in | disease | 0.85 |
| Alzheimer's Disease | involved_in | disease | 0.85 |
| Parkinson's Disease | involved_in | disease | 0.85 |
| NEUROINFLAMMATION | associated_with | process | 0.58 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.58 |
| TNF | interacts_with | gene | 0.58 |
| UBIQUITIN | interacts_with | gene | 0.58 |
| NF-KB | activates | gene | 0.58 |
| AUTOPHAGY | associated_with | process | 0.58 |
| MICROGLIA | co_discussed | entity | 0.50 |
| NEURODEGENERATION | co_discussed | entity | 0.50 |
| NLRP3 | co_discussed | entity | 0.50 |
| ISCHEMIA | co_discussed | entity | 0.50 |
| MITOCHONDRIA | co_discussed | entity | 0.50 |
| NEUROINFLAMMATION | co_discussed | entity | 0.50 |
| MULTIPLE SCLEROSIS | co_discussed | entity | 0.50 |
| PARKINSON | co_discussed | entity | 0.50 |
| PARKINSON'S | co_discussed | entity | 0.50 |
| PYROPTOSIS | co_discussed | entity | 0.50 |
| PARKINSON | contributes_to | entity | 0.50 |
| PYCARD | co_discussed | entity | 0.50 |
| TREM2 | co_discussed | entity | 0.50 |
| NEURON | co_discussed | entity | 0.50 |
| MITOPHAGY | co_discussed | entity | 0.50 |
| MACROPHAGE | co_discussed | entity | 0.50 |
| MACROPHAGES | co_discussed | entity | 0.50 |
| ASTROCYTES | activates | cell_type | 0.44 |
| NEURODEGENERATION | associated_with | process | 0.44 |
| CYTOKINES | activates | protein | 0.44 |
| ALZHEIMER'S DISEASE | activates | disease | 0.44 |
| PARKINSON'S DISEASE | activates | disease | 0.44 |
| INFLAMMATION | inhibits | process | 0.44 |
| AUTOPHAGY | degrades | process | 0.44 |
| NEURON | interacts_with | cell_type | 0.44 |
| MULTIPLE SCLEROSIS | regulates | disease | 0.35 |
| TREM2 | regulates | gene | 0.35 |
| NEURON | biomarker_for | cell_type | 0.35 |
| LYMPHOMA | interacts_with | disease | 0.35 |
| TAU | causes | protein | 0.35 |
| SQSTM1 | regulates | gene | 0.35 |
| P62 | regulates | gene | 0.35 |
| LRRK2 | interacts_with | gene | 0.35 |
| LRRK2 | activates | gene | 0.35 |
| TRAUMATIC BRAIN INJURY | interacts_with | disease | 0.35 |
| OBESITY | causes | disease | 0.35 |
| MACROPHAGES | causes | cell_type | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MICROGLIA | interacts_with | cell_type | 0.86 |
| IL-18 | regulates | gene | 0.65 |
| CASP1 | regulates | gene | 0.65 |
| COMPLEMENT | co_discussed | entity | 0.50 |
| ASTROCYTE | co_discussed | entity | 0.50 |
| ASTROCYTES | co_discussed | entity | 0.50 |
| CYTOKINE | co_discussed | entity | 0.50 |
| ALZHEIMER | co_discussed | entity | 0.50 |
| ALZHEIMER'S | co_discussed | entity | 0.50 |
| CASP1 | co_discussed | entity | 0.50 |
| IL1B | co_discussed | entity | 0.50 |
| AUTOPHAGY | co_discussed | entity | 0.50 |
| ATG5 | co_discussed | entity | 0.50 |
| DOPAMINERGIC | co_discussed | entity | 0.50 |
| AMPK | co_discussed | entity | 0.50 |
| IL-18 | activates | gene | 0.50 |
| CASP1 | interacts_with | gene | 0.50 |
| ENDOTHELIAL CELLS | activates | cell_type | 0.50 |
| DOPAMINERGIC NEURONS | activates | cell_type | 0.50 |
| HIPPOCAMPUS | activates | brain_region | 0.50 |
| AMPK | interacts_with | gene | 0.44 |
| COMPLEMENT | protects_against | protein | 0.35 |
| DEPRESSION | implicated_in | disease | 0.35 |
| ER STRESS | activates | process | 0.35 |
| CANCER | interacts_with | disease | 0.35 |
| CASP1 | expressed_in | gene | 0.35 |
| ASTROCYTES | biomarker_for | cell_type | 0.35 |
| GSH | activates | gene | 0.35 |
| DEPRESSION | interacts_with | disease | 0.35 |
| CASP3 | interacts_with | gene | 0.35 |
| BCL2 | interacts_with | gene | 0.35 |
| BDNF | interacts_with | gene | 0.35 |
| BAX | interacts_with | gene | 0.35 |
| ATG7 | activates | gene | 0.35 |
| ALPHA-SYNUCLEIN | inhibits | gene | 0.35 |
| AMYLOID-BETA | activates | protein | 0.35 |
| IMMUNE RESPONSE | interacts_with | process | 0.35 |
| ALZHEIMER'S DISEASE | biomarker_for | disease | 0.35 |
| COMPLEMENT ACTIVATION | activates | process | 0.35 |
| ANXIETY | regulates | disease | 0.35 |
| IBA1 | regulates | gene | 0.35 |
| FRONTOTEMPORAL DEMENTIA | associated_with | disease | 0.35 |
| B CELLS | interacts_with | cell_type | 0.35 |
| HIPPOCAMPUS | interacts_with | brain_region | 0.35 |
| DOPAMINERGIC NEURONS | inhibits | cell_type | 0.35 |
| CHOLESTEROL METABOLISM | activates | process | 0.35 |
| IL-10 | regulates | gene | 0.35 |
| CEREBRAL CORTEX | activates | brain_region | 0.35 |
| CORTEX | regulates | brain_region | 0.35 |
| DOPAMINERGIC NEURONS | regulates | cell_type | 0.35 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 | 0.601 | neurodegeneration | What are the mechanisms by which gut mic |
| Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S | 0.599 | neurodegeneration | What are the mechanisms by which gut mic |
| Microbial Inflammasome Priming Prevention | 0.584 | neurodegeneration | What are the mechanisms by which gut mic |
| Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in N | 0.582 | neurodegeneration | What are the mechanisms by which gut mic |
| Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Re | 0.581 | neurodegeneration | What are the mechanisms by which gut mic |
| Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neu | 0.580 | neurodegeneration | What are the mechanisms by which gut mic |
Scientific analyses that reference this entity
neuroscience | 2026-04-04 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Systemic inflammation as a central player in the initiation and development of A [PMID:40841660] | Bayraktaroglu I, Ortí-Casañ N, Van Dam D | Immunity & ageing : I & A | 2025 | 1 |
| USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent au [PMID:35900990] | ["Di Q", "Zhao X", "Tang H", "Li X", "Xi | Autophagy | 2023 | 1 |
| USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradatio [PMID:34486483] | ["Cai B", "Zhao J", "Zhang Y", "Liu Y", | Autophagy | 2022 | 1 |
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's di [PMID:41747877] | Waghmare A, Rahangdale S, Khare K, Taksa | Molecular and cellular neurosc | 2026 | 0 |
| The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peri [PMID:41569436] | Gopalakrishna PK, Che Mohd Nassir CMN, A | Cellular and molecular neurobi | 2026 | 0 |
| Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter [PMID:41687275] | Otálora-Alcaraz A, Sun MC, Hofman N, Cos | Multiple sclerosis and related | 2026 | 0 |
| NLRP3 Inflammasome and Polycystic Ovary Syndrome (PCOS): A Novel Profile in Adip [PMID:41596350] | Alenezi SA, Alshammari K, Khan R, Amer S | International journal of molec | 2026 | 0 |
| Exploring the Role of Microglial Cells in the Gut-Brain Axis Communication: A Sy [PMID:40662222] | Ortiz-Samur NS, Vijaya AK, Burokas A, Me | Journal of neurochemistry | 2025 | 0 |
| Sepsis and the Liver. [PMID:41439929] | ["Geladari E", "Kalergi A", "Evangelopou | Diseases (Basel, Switzerland) | 2025 | 0 |
| Molecular links between inflammatory bowel disease and Alzheimer's disease throu [PMID:41480321] | Durairajan SSK, Singh AK, Sulaiman SM, P | World journal of gastroenterol | 2025 | 0 |
| Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS sy [PMID:40784090] | ["Elbadry M", "Mabed M"] | Current research in translatio | 2025 | 0 |
| Δ9-Tetrahydrocannabinol and cannabidiol selectively suppress toll-like receptor [PMID:40553974] | Sermet S, Finn BM, Crawford RB, Kaminski | The Journal of pharmacology an | 2025 | 0 |
| Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346] | Borim PA, Gatto M, Mota GAF, Meirelles A | International journal of molec | 2025 | 0 |
| The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mou [PMID:39616735] | ["Li S", "Withaar C", "Rodrigues P", "Zi | Biomedicine & pharmacotherapy | 2024 | 0 |
| Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation [PMID:38808326] | Yu Y, Miao TW, Xiao W, Mao B, Du LY, Wan | Drug design, development and t | 2024 | 0 |
| GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis thro [PMID:36289519] | ["Liu M", "Li H", "Yang R", "Ji D", "Xia | Journal of neuroinflammation | 2022 | 0 |
| T cell-oriented strategies for controlling the COVID-19 pandemic. [PMID:34497383] | ["Noh J", "Jeong H", "Kim J", "Shin E"] | Nature reviews. Immunology | 2021 | 0 |
| Norethisterone and its acetate - what's so special about them? [PMID:32398290] | Huvinen E, Holopainen E, Heikinheimo O | BMJ sexual & reproductive heal | 2021 | 0 |
| Potential application value of PET/computed tomography in retroperitoneal leiomy [PMID:33741860] | ["Gao Y", "Yang Z", "Yu J", "Li N", "Wan | Nuclear medicine communication | 2021 | 0 |